The ribosomal protein L22 binds the pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress

Jennifer Jansen,Katherine E. Bohnsack,Susanne Böhlken-Fascher,Markus T. Bohnsack,Matthias Dobbelstein

DOI: https://doi.org/10.1101/2023.12.29.573614

2024-01-15

Abstract:The tumor suppressor p53, along with its antagonists MDM2 and MDM4, represents a central integrator of stress signaling. While DNA damage is the most widely explored trigger of a p53 response, stress arising from dysbalanced assembly of ribosomes in nucleoli is also linked to p53 induction. Deletions of the gene encoding the ribosomal protein L22 (RPL22; eL22) correlate with the presence of full-length mRNA in human cancer, but the mechanistic basis for this phenomenon was hitherto unknown. Here we show that L22, under conditions of ribosomal and nucleolar stress, promotes the skipping of exon 6 within the pre-mRNA. Upon L22 depletion, more full-length MDM4 is maintained, independent of treatment with nucleolar stressors, leading to diminished p53 activity and enhanced cellular proliferation. Mechanistically, L22 binds to specific RNA elements within intron 6 of that correspond to a stem-loop consensus, leading to the skipping of exon 6. This intronic RNA overlaps with the region responsible for splice regulation by ZMAT3. Targeted deletion of these intronic elements largely abolishes L22-mediated exon skipping and re-enables cell proliferation, despite nucleolar stressors such as 5-fluorouracil. L22 also governs alternative splicing of the ( ) and mRNAs. Thus, L22 serves as a signaling intermediate that integrates different layers of gene expression. Defects in ribosome synthesis lead to specific alternative splicing, ultimately triggering p53-mediated transcription and arresting cell proliferation.

Cancer Biology

What problem does this paper attempt to address?

The paper primarily explores how ribosomal protein L22 regulates the splicing of MDM4 precursor messenger RNA (pre-mRNA) under nucleolar stress conditions, and through this mechanism, activates the tumor suppressor p53.

Specifically, the study found that L22 can promote exon 6 skipping in MDM4 pre-mRNA under nucleolar stress conditions, leading to the production of a shorter and functionally restricted version of the MDM4 protein. This shorter MDM4 protein cannot effectively inhibit p53, thereby allowing p53 to be activated and trigger a series of downstream gene expression changes, ultimately leading to inhibited cell proliferation. L22 achieves this regulatory effect by binding to specific RNA elements within the MDM4 pre-mRNA.

In addition, the study also revealed that L22 is involved in regulating the splicing of other genes such as L22L1 and UBAP2L, and the interaction between L22 and another splicing regulator ZMAT3 in the regulation of MDM4 splicing.

In summary, this study aims to understand how ribosomal protein L22 acts as a signaling molecule to integrate changes at multiple levels of gene expression under nucleolar stress, to activate p53-mediated transcriptional responses, and ultimately inhibit cell proliferation.